After all the math is done on the deals between Novartis AG, GlaxoSmithKline plc and Eli Lilly and Co., Novartis' net outlay including upfront payments and near-term milestones could reach $5.3 billion by the time the deals close.

Novartis will pay $14.5 billion up front and up to $1.5 billion in